Search research articles
Contact Us
Filters
Showing results (141-150 of 487) with videos related to
Page
of 49
Sort By:
American Journal of Hematology
|
April 6, 2001
A pilot study of rhuIL-11 treatment of refractory ITP
J B Bussel, R Mukherjee, A J Stone
British Journal of Haematology
|
September 27, 2003
Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy
Marc Michel, Maria V Novoa, James B Bussel
American Journal of Hematology
|
March 1, 1990
Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: more is not always better
J B Bussel, J Fitzgerald-Pedersen, C Feldman
American Journal of Hematology
|
April 24, 2019
Response to thrombopoietic agents is related to on-treatment bone marrow megakaryocyte morphology in patients with chronic immune thrombocytopenia
Marie Hogan, Julia T Geyer, James B Bussel
British Journal of Haematology
|
September 22, 2023
The role of genetics in refractory immune thrombocytopenia
James L Zehnder, James B Bussel, Nichola Cooper
British Journal of Haematology
|
May 2, 2025
The paradox of autoimmune thrombocytopenia in common variable immunodeficiency
Brit Trogen, Charlotte Cunningham-Rundles, James B Bussel
The New England Journal of Medicine
|
November 1, 2023
Primary Immune Thrombocytopenia in Pregnancy. Reply
James B Bussel, Ming Hou, Douglas B Cines
Blut
|
July 1, 1989
Antenatal treatment of fetal alloimmune cytopenias
J B Bussel, J G McFarland, R Berkowitz
The Journal of Biological Chemistry
|
February 10, 1971
Conformational changes in aspartate transcarbamylase. 3. A functional model for allosteric behavior
G Markus, D K McClintock, J B Bussel
Current Opinion in Oncology
|
October 9, 2008
The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia
Benjamin Levy, Jon E Arnason, James B Bussel
Page
of 49
Search research articles
Search
Showing results (141-150 of 487) with videos related to
Sort By:
Page
of 49
American Journal of Hematology
|
April 6, 2001
A pilot study of rhuIL-11 treatment of refractory ITP
J B Bussel, R Mukherjee, A J Stone
British Journal of Haematology
|
September 27, 2003
Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy
Marc Michel, Maria V Novoa, James B Bussel
American Journal of Hematology
|
March 1, 1990
Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: more is not always better
J B Bussel, J Fitzgerald-Pedersen, C Feldman
American Journal of Hematology
|
April 24, 2019
Response to thrombopoietic agents is related to on-treatment bone marrow megakaryocyte morphology in patients with chronic immune thrombocytopenia
Marie Hogan, Julia T Geyer, James B Bussel
British Journal of Haematology
|
September 22, 2023
The role of genetics in refractory immune thrombocytopenia
James L Zehnder, James B Bussel, Nichola Cooper
British Journal of Haematology
|
May 2, 2025
The paradox of autoimmune thrombocytopenia in common variable immunodeficiency
Brit Trogen, Charlotte Cunningham-Rundles, James B Bussel
The New England Journal of Medicine
|
November 1, 2023
Primary Immune Thrombocytopenia in Pregnancy. Reply
James B Bussel, Ming Hou, Douglas B Cines
Blut
|
July 1, 1989
Antenatal treatment of fetal alloimmune cytopenias
J B Bussel, J G McFarland, R Berkowitz
The Journal of Biological Chemistry
|
February 10, 1971
Conformational changes in aspartate transcarbamylase. 3. A functional model for allosteric behavior
G Markus, D K McClintock, J B Bussel
Current Opinion in Oncology
|
October 9, 2008
The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia
Benjamin Levy, Jon E Arnason, James B Bussel
Page
of 49